Invictus Oncology Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
- Paid Up Capital ₹ 2.06 Cr
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1534.01%
- Profit Growth 13.70%
- Ebitda 43.76%
- Net Worth -3.09%
- Total Assets -2.85%
About Invictus Oncology
Invictus Oncology Private Limited (IOPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 April 2011 and has a history of 14 years and one month. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 2.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
Raghunath Mashelkar, Shiladitya Sengupta, Rajeev Mantri, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232DL2011PTC217394
- Company No.
217394
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Invictus Oncology Private Limited
Explore comprehensive data for Invictus Oncology Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Invictus Oncology?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jasmin Patel  | Nominee Director | 04-Feb-2013 | Current |
| Raghunath Mashelkar | Director | 04-Feb-2013 | Current |
| Shiladitya Sengupta | Director | 11-Apr-2011 | Current |
| Rajeev Mantri | Nominee Director | 11-Apr-2011 | Current |
Financial Performance of Invictus Oncology.
Invictus Oncology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1534.01% increase. The company also saw a substantial improvement in profitability, with a 13.7% increase in profit. The company's net worth dipped by a decrease of 3.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Invictus Oncology?
In 2020, Invictus Oncology had a promoter holding of 89.73% and a public holding of 10.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vyome Therapeutics LimitedRaghunath Mashelkar and Shiladitya Sengupta are mutual person
Vyome Biosciences Private LimitedShiladitya Sengupta and Rajeev Mantri are mutual person
International Longevity Centre- IndiaRaghunath Mashelkar is a mutual person
Gpsk Commodities Private LimitedRajeev Mantri is a mutual person
- Gpsk Capital Private Limited
Rajeev Mantri is a mutual person
Sakal Media Private LimitedRaghunath Mashelkar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Invictus Oncology?
Unlock and access historical data on people associated with Invictus Oncology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Invictus Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invictus Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Invictus Oncology
Recent activity within the organization
- Annual General Meeting
Invictus Oncology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Invictus Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Director Appointment
Raghunath Anant Mashelkar was appointed as a Director was appointed as a Director on 04 Feb 2013 & has been associated with this company since 12 years 3 months .
- Director Appointment
Jasmin Rambhai Patel was appointed as a Nominee Director was appointed as a Nominee Director on 04 Feb 2013 & has been associated with this company since 12 years 3 months .
- Director Appointment
Shiladitya Sengupta was appointed as a Director was appointed as a Director on 11 Apr 2011 & has been associated with this company since 14 years 1 month .
- Director Appointment
Rajeev Mantri was appointed as a Nominee Director was appointed as a Nominee Director on 11 Apr 2011 & has been associated with this company since 14 years 1 month .
Recent News, Updates & Announcement
- Invictus Oncology raises `10.5 crore from Navam Capital, Aarin Capital | Mint.
Invictus says it will deploy funds in developing platinum chemotherapies used in treatment of several types of cancer.
Frequently asked questions
What is the Incorporation or founding date of Invictus Oncology Private Limited?
Invictus Oncology Private Limited was incorporated on 11 Apr 2011.
What is authorized share capital and paid-up capital of Invictus Oncology Private Limited?
The authorized share capital of Invictus Oncology Private Limited is ₹ 2.10 Cr and paid-up capital is ₹ 2.06 Cr.
Who are the current board members & directors of Invictus Oncology Private Limited?
Currently 4 directors are associated with Invictus Oncology Private Limited.
- Raghunath Anant Mashelkar
- Shiladitya Sengupta
- Rajeev Mantri
- Jasmin Rambhai Patel
What is the registered address of Invictus Oncology Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Invictus Oncology Private Limited is Plot No. 465; F.I.E. 1St Floor, Pathparganj Industrial Area India, Delhi, 110092.
What is the corporate identification number (CIN) and company number of Invictus Oncology Private Limited?
The corporate identification number (CIN) of Invictus Oncology Private Limited is U24232DL2011PTC217394 and the company number is 217394 as per Ministry of Corporate Affairs (MCA).
What is the official website of Invictus Oncology Private Limited?
The Official website of Invictus Oncology Private Limited is https://www.invictusoncology.com
What has been the recent revenue trend for Invictus Oncology Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Invictus Oncology Private Limited has risen by 1534.01%.
What change has been observed in the net worth of Invictus Oncology Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Invictus Oncology Private Limited has experienced an downturn of -3.09%.
When was the last Balance Sheet of Invictus Oncology Private Limited filed with the ROC?
The most recent Balance Sheet for Invictus Oncology Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records